|
Hematologic Cancer Research Studies
ACUTE MYELOID LEUKEMIA
C10603 A Phase III
Randomized, Double-Blind Study of Induction (Daunorubicin / Cytarabine) and
Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin or Placebo in
Newly Diagnosed Patients < 60 Years of Age with FLT3 Mutated Acute Myeloid
Leukemia (AML)
ACUTE LYMPHOBLASTIC LEUKEMIA
10403 An
Intergroup Phase II Clinical Trial for Adolescents and Young Adults with
Untreated Acute Lymphoblatsic Leukemia (ALL)
MYELODYSPLASTIC SYNDROME
E2905 Randomized
Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to
Treatment with Lenalidomide (Revlimid®) Alone and in Combination
with Epoetin Alfa (Procrit®) in Subjects with Low- or Intermediate-
1 Risk MDS and Symptomatic Anemia
ACUTE PROMYELOCYTIC LEUKEMIA
S0535 A
Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients
with Previously Untreated High-Risk Acute Promyelocytic Leukemia (temporarily
suspended)
MANTLE CELL LYMPHOMA
N078D Phase
I / II Trial of Rituximab, Cladribine, and Temsirolimus (RCT) Therapy in Newly
Diagnosed Mantle Cell Lymphoma (MCL)
CHRONIC LYMPHOCYTIC LEUKEMIA
10404 A
Genetic Risk-Stratified Randomized Phase II Study of Four Fludarabine / Antibody
Combinations for Patients with Symptomatic, Previously Untreated Chronic
Lymphocytic Leukemia
E2903 A
Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by
Campath-1H for Previously Treated Relapsed of Refractory Patients with Chronic
Lymphocytic Leukemia
RC0783 Randomized
Phase II Trial of Pentostatin, Cyclophosphamide, and Rituximab with or without
Concurrent Avastin® for Previously Untreated B-Chronic Lymphocytic
Leukemia (CLL)
MYELOMA
E1A06 An
Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone
and Thalidomide Versus Melphalan, Prednisone and Lenalidomide in Newly Diagnosed
Myeloma Patients who are Not Candidates for High-Dose Therapy
CANCER CONTROL
C70604 A Randomized, Phase
III Study of Standard Dosing Versus Longer Dosing Interval of Zoledronic Acid in
Metastatic Cancer
|